BBIO EBITDA
Bridgebio Pharma Inc · EBITDA
BBIO EBITDA
Latest reported-$611.26Mperiod ending
BBIO TTM EBITDA (-$166.66M → -$611.26M)
TTM EBITDA
High-resolution chart · PNG
BBIO ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -611,262,000 | |
| -612,406,000 | |
| -626,035,000 | |
| -677,280,000 | |
| -643,590,000 | |
| -551,919,000 | |
| -436,829,000 | |
| -350,256,000 | |
| -368,144,000 | |
| -455,583,000 | |
| -565,468,000 | |
| -535,913,000 | |
| -497,093,000 | |
| -339,319,000 | |
| -397,443,000 | |
| -414,145,000 | |
| -445,106,000 | |
| -552,157,000 | |
| -533,833,000 | |
| -521,839,000 | |
| -491,052,667 | |
| -527,268,667 | |
| -466,021,667 | |
| -423,130,667 | |
| -362,410,000 | |
| -310,838,000 | |
| -279,072,000 | |
| -246,297,000 | |
| -228,965,000 | |
| -192,027,000 | |
| -166,659,000 |